CytoSPAR, Inc. — Form D
CytoSPAR, Inc. of PLANO, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-03. The offering totals $5.0M, of which $2.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-05-03
- Form: D
- Accession: 0001923117-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.0M
- Remaining: $3.0M
- Investors: 6
- Date of first sale: 2022-04-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-444217
Issuer
- Name: CytoSPAR, Inc.
- CIK: 0001923117
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 7700 WINDROSE, #G300, PLANO, TX, 75024
- Phone: 484-661-6306
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Mark Allen | Director | Grand Island, NE |
| William Weisman | Director | Los Angeles, CA |
| Russell Williams | Director | Plano, TX |
| Russell Williams | Executive Officer | Plano, TX |
More